Literature DB >> 20227382

Identification of a second DNA binding site in human DNA methyltransferase 3A by substrate inhibition and domain deletion.

Matthew M Purdy1, Celeste Holz-Schietinger, Norbert O Reich.   

Abstract

The human DNA methyltransferase 3A (DNMT3A) is essential for establishing DNA methylation patterns. Knowing the key factors involved in the regulation of mammalian DNA methylation is critical to furthering understanding of embryonic development and designing therapeutic approaches targeting epigenetic mechanisms. We observe substrate inhibition for the full length DNMT3A but not for its isolated catalytic domain, demonstrating that DNMT3A has a second binding site for DNA. Deletion of recognized domains of DNMT3A reveals that the conserved PWWP domain is necessary for substrate inhibition and forms at least part of the allosteric DNA binding site. The PWWP domain is demonstrated here to bind DNA in a cooperative manner with muM affinity. No clear sequence preference was observed, similar to previous observations with the isolated PWWP domain of Dnmt3b but with one order of magnitude weaker affinity. Potential roles for a low affinity, low specificity second DNA binding site are discussed. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227382     DOI: 10.1016/j.abb.2010.03.007

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  22 in total

1.  Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation.

Authors:  Celeste Holz-Schietinger; Doug M Matje; Norbert O Reich
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

2.  Dnmt3a-CD is less susceptible to bulky benzo[a]pyrene diol epoxide-derived DNA lesions than prokaryotic DNA methyltransferases.

Authors:  Olga V Lukashevich; Vladimir B Baskunov; Maria V Darii; Alexander Kolbanovskiy; Alexander A Baykov; Elizaveta S Gromova
Journal:  Biochemistry       Date:  2011-01-13       Impact factor: 3.162

3.  The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.

Authors:  David A Russler-Germain; David H Spencer; Margaret A Young; Tamara L Lamprecht; Christopher A Miller; Robert Fulton; Matthew R Meyer; Petra Erdmann-Gilmore; R Reid Townsend; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

4.  Role of the PWWP domain of lens epithelium-derived growth factor (LEDGF)/p75 cofactor in lentiviral integration targeting.

Authors:  Rik Gijsbers; Sofie Vets; Jan De Rijck; Karen E Ocwieja; Keshet Ronen; Nirav Malani; Frederic D Bushman; Zeger Debyser
Journal:  J Biol Chem       Date:  2011-10-10       Impact factor: 5.157

5.  The R882H substitution in the human de novo DNA methyltransferase DNMT3A disrupts allosteric regulation by the tumor supressor p53.

Authors:  Jonathan E Sandoval; Norbert O Reich
Journal:  J Biol Chem       Date:  2019-10-22       Impact factor: 5.157

6.  Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.

Authors:  Christopher B Cole; David A Russler-Germain; Shamika Ketkar; Angela M Verdoni; Amanda M Smith; Celia V Bangert; Nichole M Helton; Mindy Guo; Jeffery M Klco; Shelly O'Laughlin; Catrina Fronick; Robert Fulton; Gue Su Chang; Allegra A Petti; Christopher A Miller; Timothy J Ley
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

Review 7.  DNMT3A in haematological malignancies.

Authors:  Liubin Yang; Rachel Rau; Margaret A Goodell
Journal:  Nat Rev Cancer       Date:  2015-02-19       Impact factor: 60.716

8.  Oligomerization of DNMT3A controls the mechanism of de novo DNA methylation.

Authors:  Celeste Holz-Schietinger; Douglas M Matje; Madeleine Flexer Harrison; Norbert O Reich
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

Review 9.  PWWP domains and their modes of sensing DNA and histone methylated lysines.

Authors:  Germana B Rona; Elis C A Eleutherio; Anderson S Pinheiro
Journal:  Biophys Rev       Date:  2016-01-14

10.  Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.

Authors:  Jonathan E Sandoval; Yung-Hsin Huang; Abigail Muise; Margaret A Goodell; Norbert O Reich
Journal:  J Biol Chem       Date:  2019-01-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.